Nuffield Department of Population Health (YG, DQ), University of Oxford, Oxford, UK.
School of Population Medicine and Public Health (BS), Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.
Am J Geriatr Psychiatry. 2024 Sep;32(9):1154-1165. doi: 10.1016/j.jagp.2024.04.010. Epub 2024 Apr 21.
We aimed to investigate the association of regular opioid use, compared with non-opioid analgesics, with incident dementia and neuroimaging outcomes among chronic pain patients.
The primary design is a prospective cohort study. To triangulate evidence, we also conducted a nested case-control study analyzing opioid prescriptions and a cross-sectional study analyzing neuroimaging outcomes.
Dementia-free UK Biobank participants with chronic pain and regular analgesic use.
Chronic pain status and regular analgesic use were captured using self-reported questionnaires and verbal interviews. Opioid prescription data were obtained from primary care records. Dementia cases were ascertained using primary care, hospital, and death registry records. Propensity score-matched Cox proportional hazards analysis, conditional logistic regression, and linear regression were applied to the data in the prospective cohort, nested case-control, and cross-sectional studies, respectively.
Prospective analyses revealed that regular opioid use, compared with non-opioid analgesics, was associated with an increased dementia risk over the 15-year follow-up (Hazard ratio [HR], 1.18 [95% confidence interval (CI): 1.08-1.30]; Absolute rate difference [ARD], 0.44 [95% CI: 0.19-0.71] per 1000 person-years; Wald χ = 3.65; df = 1; p <0.001). The nested case-control study suggested that a higher number of opioid prescriptions was associated with an increased risk of dementia (1 to 5 prescriptions: OR = 1.21, 95% CI: 1.07-1.37, Wald χ = 3.02, df = 1, p = 0.003; 6 to 20: OR = 1.27, 95% CI: 1.08-1.50, Wald χ = 2.93, df = 1, p = 0.003; more than 20: OR = 1.43, 95% CI: 1.23-1.67, Wald χ = 4.57, df = 1, p < 0.001). Finally, neuroimaging analyses revealed that regular opioid use was associated with lower total grey matter and hippocampal volumes, and higher white matter hyperintensities volumes.
Regular opioid use in chronic pain patients was associated with an increased risk of dementia and poorer brain health when compared to non-opioid analgesic use. These findings imply a need for re-evaluation of opioid prescription practices for chronic pain patients and, if further evidence supports causality, provide insights into strategies to mitigate the burden of dementia.
我们旨在研究与非阿片类镇痛药相比,慢性疼痛患者常规使用阿片类药物与新发痴呆症和神经影像学结果之间的关联。
主要设计是一项前瞻性队列研究。为了进行三角测量,我们还进行了嵌套病例对照研究,分析阿片类药物处方,并进行了横断面研究,分析神经影像学结果。
无痴呆症的英国生物银行慢性疼痛且有规律使用镇痛药的参与者。
慢性疼痛状况和常规镇痛药使用情况通过自我报告问卷和口头访谈进行评估。阿片类药物处方数据从初级保健记录中获得。痴呆病例通过初级保健、医院和死亡登记记录确定。在前瞻性队列研究、嵌套病例对照研究和横断面研究中,分别应用了倾向评分匹配的 Cox 比例风险分析、条件逻辑回归和线性回归。
前瞻性分析显示,与非阿片类镇痛药相比,常规使用阿片类药物与 15 年随访期间的痴呆风险增加相关(风险比 [HR],1.18 [95%置信区间 (CI):1.08-1.30];绝对率差异 [ARD],每 1000 人年 0.44 [95%CI:0.19-0.71];Wald χ = 3.65;df = 1;p <0.001)。嵌套病例对照研究表明,阿片类药物处方数量较多与痴呆风险增加相关(1-5 张处方:OR = 1.21,95%CI:1.07-1.37,Wald χ = 3.02,df = 1,p = 0.003;6-20 张:OR = 1.27,95%CI:1.08-1.50,Wald χ = 2.93,df = 1,p = 0.003;超过 20 张:OR = 1.43,95%CI:1.23-1.67,Wald χ = 4.57,df = 1,p < 0.001)。最后,神经影像学分析显示,与非阿片类镇痛药相比,慢性疼痛患者常规使用阿片类药物与总灰质和海马体积减少以及白质高信号体积增加相关。
与非阿片类镇痛药相比,慢性疼痛患者常规使用阿片类药物与痴呆风险增加和大脑健康状况恶化相关。这些发现意味着需要重新评估慢性疼痛患者的阿片类药物处方实践,如果进一步的证据支持因果关系,则为减轻痴呆症负担提供了见解。